Loading
Latest filing published 30 Dec 2025 for ASCENTAGE PHARMA GROUP INTERNATIONAL.
No signal scores available.
Not enough history yet: 0 closed purchases, at least 2 are needed.
This profile gathers the share dealings of LU Simon Dazhong in Ascentage Pharma Group International. In total, 2 filings cover trades dated 26 November 2025.
No open-market sale appears; the market trades are 2 purchases. The totals exclude 2 filings filed without an amount. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket.
The latest filing, published on 30 December 2025, reports an open-market purchase in Ascentage Pharma Group International. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 of 2 declarations